Last reviewed · How we verify

[68Ga]Ga-DPI-4452

ITM Oncologics GmbH · Phase 1 active Small molecule Quality 0/100

[68Ga]Ga-DPI-4452 is a Small molecule drug developed by ITM Oncologics GmbH. It is currently in Phase 1 development.

At a glance

Generic name[68Ga]Ga-DPI-4452
SponsorITM Oncologics GmbH
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about [68Ga]Ga-DPI-4452

What is [68Ga]Ga-DPI-4452?

[68Ga]Ga-DPI-4452 is a Small molecule drug developed by ITM Oncologics GmbH.

Who makes [68Ga]Ga-DPI-4452?

[68Ga]Ga-DPI-4452 is developed by ITM Oncologics GmbH (see full ITM Oncologics GmbH pipeline at /company/itm-oncologics-gmbh).

What development phase is [68Ga]Ga-DPI-4452 in?

[68Ga]Ga-DPI-4452 is in Phase 1.

Related